C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 57/60 (2006.01) A61K 31/192 (2006.01) A61P 9/00 (2006.01) A61P 13/08 (2006.01) A61P 13/10 (2006.01) A61P 19/10 (2006.01)
Patent
CA 2403144
The present invention describes novel halogenated triphenylethylene derivatives, or pharmaceutically acceptable prodrug or salt forms thereof, as selective estrogen receptor modulators for the treatment of and/or prevention of breast, uterine, ovarian, prostrate and colon cancer, osteoporosis, cardiovascular disease, and benign proliferative disorders, as well as methods for making the compounds and pharmaceutical compositions of this invention.
La présente invention concerne de nouveaux dérivés de triphényléthylène halogéné ou bien un promédicament ou les formes salines pharmaceutiquement acceptables de ces derniers, qu'on utilise en tant que modulateurs sélectifs vis-à-vis du récepteur des oestrogènes pour le traitement et/ou la prévention du cancer du sein, de l'utérus, de l'ovaire, de la prostate et du colon, l'ostéoporose, les maladies cardio-vasculaires et les affections prolifératives bénignes. L'invention se rapporte également à des procédés de préparation des composés et des compositions pharmaceutiques selon l'invention.
Kaltenbach Robert F. III
Trainor George L.
Bristol-Myers Squibb Pharma Company
Dimock Stratton Llp
LandOfFree
Halogenated triphenylethylene derivatives as selective... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Halogenated triphenylethylene derivatives as selective..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Halogenated triphenylethylene derivatives as selective... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1999323